期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Synthesis of Metallic Nanoparticles Based on Green Chemistry and Their Medical Biochemical Applications:Synthesis of Metallic Nanoparticles 被引量:1
1
作者 Kakudji Kisimba anand krishnan +4 位作者 Mbuso Faya Kahumba Byanga Kabange Kasumbwe Kaliyapillai Vijayakumar Ram Prasad 《Journal of Renewable Materials》 SCIE EI 2023年第6期2575-2591,共17页
Nanoparticles have distinct properties that make them potentially valuable in a variety of industries.As a result,emerging approaches for the manufacture of nanoparticles are gaining a lot of scientific interest.The b... Nanoparticles have distinct properties that make them potentially valuable in a variety of industries.As a result,emerging approaches for the manufacture of nanoparticles are gaining a lot of scientific interest.The biological pathway of nanoparticle synthesis has been suggested as an effective,affordable,and environmentally safe method.Synthesis of nanoparticles through physical and chemical processes uses unsafe materials,expensive equipment and adversely affects the environment.As a result,in order to support the increased utilization of nanoparticles across many sectors,nanotechnology research activities have shifted toward environmentally safe and cost-effective techniques that outperform chemical and/or biological procedures.The use of organisms to produce metal nanoparticles is among the most frequently discussed methods.Plants appear to be the best candidates among these organisms for large-scale nanoparticle biosynthesis.Medicinal plants have been employed as reducing agents and NP stabilizers to minimize the toxicity of NPs in both the environment and the human body.Furthermore,the presence of certain functional components in plant extracts may be extremely useful and effective for the human body.Polyphenol,for example,which may have antioxidant properties,might intercept free radicals before they interact with other biomolecules and cause considerable damage.The current article analyzes the most recent developments and improvements in the green synthesis of metal nanoparticles by different plants and the use of these nanoparticles for various biomedical applications and hopes to provide insights into this exciting research frontier. 展开更多
关键词 BIOSYNTHESIS NANOPARTICLES ANTIMICROBIAL ANTICANCER ANTIOXIDANT medicinal plants
在线阅读 下载PDF
Self-renewal of peripheral nerve resident macrophage:does it represent a unique activation status?
2
作者 Maricris Bautista anand krishnan 《Neural Regeneration Research》 SCIE CAS CSCD 2022年第5期999-1000,共2页
Macrophages are immune cells of myeloid origin and are present in almost all tissues.They perform a wide variety of functions contributing to tissue development,homeostasis,pathogenesis,and repair(Wynn et al.,2013).St... Macrophages are immune cells of myeloid origin and are present in almost all tissues.They perform a wide variety of functions contributing to tissue development,homeostasis,pathogenesis,and repair(Wynn et al.,2013).Strikingly,macrophages residing at different tissues,and at different compartments of an individual tissue,demonstrate enormously diverse molecular characteristics(Gordon and Taylor,2005). 展开更多
关键词 al. HOMEOSTASIS MACROPHAGE
暂未订购
Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers
3
作者 Narmadha Rathinasamy Sathish Muthu anand krishnan 《World Journal of Clinical Cases》 SCIE 2023年第17期3976-3979,共4页
Neo-adjuvant chemotherapy(NACT)is utilized in locally advanced oral cancers to reduce the tumor burden and downstage the tumor to be amenable for definitive surgical management.Its long-term results compared to upfron... Neo-adjuvant chemotherapy(NACT)is utilized in locally advanced oral cancers to reduce the tumor burden and downstage the tumor to be amenable for definitive surgical management.Its long-term results compared to upfront surgical resection was not encouraging.Immunotherapy has now been used not only in recurrence and metastatic setting but also in the locally advanced tumor management regimens.The purpose of this concept paper is to bring forward the rationale to use a fixed low-dose immunotherapy agent as a potentiator to the standard NACT regimen and recommend their future investigation in oral cancer management. 展开更多
关键词 IMMUNOTHERAPY Neo-adjuvant chemotherapy Oral cancer
暂未订购
Schwann cells modified to secrete MANF is a potential cellular therapy for peripheral nerve regeneration
4
作者 Bhadrapriya Sivakumar Caleb Hammond +4 位作者 Valeria Martinez Nickson Joseph Johnson V.John Anil Kumar anand krishnan 《Cell Regeneration》 2025年第6期60-74,共15页
Effective therapies for peripheral nerve repair are still lacking despite active research in this field over the past years.The limited knowledge of biomolecules that equally promote axon regeneration and glial cell d... Effective therapies for peripheral nerve repair are still lacking despite active research in this field over the past years.The limited knowledge of biomolecules that equally promote axon regeneration and glial cell dynamics,which are critical for nerve regeneration,poses a major challenge in developing effective therapies.Here,we showed that the neurotrophic factor mesencephalic astrocyte-derived neurotrophic factor(MANF)equally promotes axon regeneration and glial cell dynamics favorable for nerve regeneration.Using adult rodent models,we showed that the endogenous expression of MANF is restricted to non-peptidergic sensory neurons.However,supplementation of exogenous MANF promoted the growth of all subtypes of adult sensory neurons.We also demonstrated that exogenous MANF promotes the proliferation and migration of adult primary Schwann Cells(SCs).Furthermore,we showed that local and repeated administration of MANF to injured nerves promotes axon regeneration in mice models.Finally,we devised a therapeutic approach by programming nerve-resident SCs to locally and continuously deliver MANF to injured nerves and showed that this approach improves axon regeneration.Overall,this work developed a therapeutic approach by harnessing the power of SCs as a local delivery system for MANF for nerve repair. 展开更多
关键词 MANF Nerve regeneration Schwann cell Sensory neuron Neurite outgrowth Dorsal root ganglia Nerve explant Nerve repair Cell plasticity Peripheral nerves
暂未订购
2019年全球、地区和国家5岁以下儿童呼吸道合胞病毒引发急性下呼吸道感染疾病负担研究的系统分析 被引量:12
5
作者 You Li Xin Wang +49 位作者 Dianna M.Blau Mauricio T.Caballero Daniel R.Feikin Christopher J.Gill Shabir A.Madhi Saad B.Omer Eric A.F Simoes Harry Campbell Ana Bermejo Pariente Darmaa Bardach Quique Bassat Jean-Sebastien Casalegno Giorgi Chakhunashvili Nigel Crawford Daria Danilenko Lien Anh Ha Do Marcela Echavarria Angela Gentile Aubree Gordon Terho Heikkinen QSue Huang Sophie Jullien anand krishnan Eduardo Luis Lopez Josko Markic Ainara Mira-Iglesias Hannah CMoore Jocelyn Moyes Lawrence Mwananyanda DJames Nokes Faseeha Noordeen Evangeline Obodai Nandhini Palani Candice Romero Vahid Salimi Ashish Satav Euri Seo Zakhar Shchomak Rosalyn Singleton Kirill Stolyarov Sonia K Stoszek Anne von Gottberg Danielle Wurzel Lay-Myint Yoshida Chee Fu Yung Heather J Zar Harish Nair 张甜甜 从兵兵 邓舒予 《中国病毒病杂志》 CAS 2023年第2期81-95,共15页
背景呼吸道合胞病毒(respiratory syncytial virus,RSV)是引起婴幼儿急性下呼吸道感染最常见的病原体。此前估计,2015年全球60月龄以下儿童共发生3 310万次RSV相关急性下呼吸道感染,导致118 200人死亡。此后,几项社区监测研究获得了对RS... 背景呼吸道合胞病毒(respiratory syncytial virus,RSV)是引起婴幼儿急性下呼吸道感染最常见的病原体。此前估计,2015年全球60月龄以下儿童共发生3 310万次RSV相关急性下呼吸道感染,导致118 200人死亡。此后,几项社区监测研究获得了对RSV相关社区死亡的更精确估计。本文旨在更新2019年全球、地区和国家层面60月龄以下儿童RSV相关急性下呼吸道感染的发病率和死亡率,重点关注总体死亡率和在研RSV免疫制剂针对的更窄的婴儿年龄组。方法 检索获得MEDLINE、Embase、Global Health、CINAHL、Web of Science、LILACS、OpenGrey、中国知网、万方和维普数据库2017—2020年发表文献中的新数据,并纳入RSV GEN合作者提供的未发表数据,以扩展全球RSV疾病负担数据集。纳入的研究符合以下条件:报告了社区中或需要住院治疗的60月龄以下儿童RSV原发性急性下呼吸道感染的数据;报告了至少连续12个月的数据,但院内病死率或RSV季节性定义明确的地区除外;报告了RSV相关急性下呼吸道感染的发病率、住院率、院内病死率或急性下呼吸道感染住院的RSV阳性比例。如果病例定义不明或应用不一致、RSV感染未经实验室确认或仅基于血清学检测、报告的急性下呼吸道感染病例少于50例,则排除该研究。本研究应用广义线性混合效应模型(generalized linear mixed-effects model,GLMM)估计了2019年全球和地区(按国家发展状况和世界银行收入分类)RSV相关急性下呼吸道感染的发病率、住院率和院内病死率;通过基于危险因素的模型估计了国家层面RSV相关急性下呼吸道感染的发病率;通过GLMM开发了新模型,纳入最新的RSV社区死亡率数据,用于估计RSV的总体死亡率。本综述已在PROSPERO注册(CRD42021252400)。结果 除了先前综述中纳入的317项研究外,还纳入了113项符合条件的新研究以及51项未发表的研究,共计481项研究。据估计,2019年全球60月龄以下儿童中,共发生3 300万(置信区间为2 540万~4 460万)次RSV相关急性下呼吸道感染,导致360万(290万~460万)例住院、26 300(15 100~49 100)例院内死亡以及101 400(84 500~125 200)例可归因于RSV的总死亡数。在0~6个月的婴儿中,共发生660万(460万~970万)次RSV相关急性下呼吸道感染,导致140万(100万~200万)例住院、13 300(6 800~28 100)例院内死亡以及45 700(38 400~55 900)例可归因于RSV的总死亡数。60月龄以下和28 d~6月龄儿童的死亡中分别有2.0%(置信区间为1.6%~2.4%)和3.6%(3.0%~4.4%)归因于RSV。在各年龄组中,95%以上的RSV相关急性下呼吸道感染事件和97%以上的可归因于RSV的死亡事件都发生在中低收入国家。结论 RSV显著增加了全球60月龄以下儿童的发病和死亡负担,尤其是在出生后前6个月和中低收入国家。本研究强调了全球RSV疾病的总体死亡率负担,60月龄以下儿童中,每50例死亡就有1例可归因于RSV;28 d至6个月大的婴儿中,每28例死亡就有1例可归因于RSV。每1例RSV相关急性下呼吸道感染院内死亡,对应社区中约3例可归因于RSV的死亡。对6月龄内婴儿提供保护的RSV被动免疫计划有望对减轻RSV疾病负担,但实施计划时,仍需要更多数据来了解RSV疾病负担高峰可能向大龄转移的影响。 展开更多
关键词 呼吸道合胞病毒 下呼吸道感染 儿童 疾病负担 住院 发病率 死亡率 病死率 模型估计 系统分析
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部